The insulin-sensitizing drugs TZDs, as PPARγ agonists, have beneficial effects on serum lipids in diabetic patients and have also been shown to inhibit the progression of atherosclerosis in animal models [17]. The gene discussed is INS; the disease is atherosclerosis.